Huons Global Co. Ltd (084110) - Total Assets
Based on the latest financial reports, Huons Global Co. Ltd (084110) holds total assets worth ₩1.47 Trillion KRW (≈ $998.36 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 084110 book value for net asset value and shareholders' equity analysis.
Huons Global Co. Ltd - Total Assets Trend (2010–2025)
This chart illustrates how Huons Global Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Huons Global Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Huons Global Co. Ltd's total assets of ₩1.47 Trillion consist of 39.3% current assets and 60.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 12.4% |
| Accounts Receivable | ₩163.27 Billion | 10.5% |
| Inventory | ₩134.45 Billion | 8.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩41.48 Billion | 2.7% |
| Goodwill | ₩123.00 Billion | 7.9% |
Asset Composition Trend (2010–2025)
This chart illustrates how Huons Global Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Huons Global Co. Ltd (084110) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Huons Global Co. Ltd's current assets represent 39.3% of total assets in 2025, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 12.4% of total assets in 2025, up from 1.8% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 4.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 10.5% of total assets.
Huons Global Co. Ltd Competitors by Total Assets
Key competitors of Huons Global Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Theragen Etex Co.Ltd
KQ:066700
|
Korea | ₩245.25 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩233.98 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩87.88 Billion |
|
Kolon Life Science Inc
KQ:102940
|
Korea | ₩642.14 Billion |
Huons Global Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.96 | 1.85 | 1.80 |
| Quick Ratio | 1.50 | 1.42 | 1.43 |
| Cash Ratio | 0.00 | 0.82 | 0.00 |
| Working Capital | ₩295.56 Billion | ₩251.86 Billion | ₩189.95 Billion |
Huons Global Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Huons Global Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.26 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 11.0% |
| Total Assets | ₩1.56 Trillion |
| Market Capitalization | $463.90 Million USD |
Valuation Analysis
Below Book Valuation: The market values Huons Global Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Huons Global Co. Ltd's assets grew by 11.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Huons Global Co. Ltd (2010–2025)
The table below shows the annual total assets of Huons Global Co. Ltd from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩1.56 Trillion ≈ $1.06 Billion |
+10.95% |
| 2024-12-31 | ₩1.41 Trillion ≈ $952.79 Million |
+6.68% |
| 2023-12-31 | ₩1.32 Trillion ≈ $893.17 Million |
+6.02% |
| 2022-12-31 | ₩1.24 Trillion ≈ $842.44 Million |
-3.17% |
| 2021-12-31 | ₩1.28 Trillion ≈ $869.98 Million |
+35.27% |
| 2020-12-31 | ₩949.02 Billion ≈ $643.14 Million |
+27.87% |
| 2019-12-31 | ₩742.15 Billion ≈ $502.95 Million |
+10.30% |
| 2018-12-31 | ₩672.88 Billion ≈ $456.00 Million |
+10.28% |
| 2017-12-31 | ₩610.15 Billion ≈ $413.49 Million |
+9.53% |
| 2016-12-31 | ₩557.06 Billion ≈ $377.51 Million |
+77.33% |
| 2015-12-31 | ₩314.13 Billion ≈ $212.88 Million |
+23.42% |
| 2014-12-31 | ₩254.51 Billion ≈ $172.48 Million |
+23.42% |
| 2013-12-31 | ₩206.22 Billion ≈ $139.76 Million |
+11.16% |
| 2012-12-31 | ₩185.52 Billion ≈ $125.72 Million |
+30.87% |
| 2010-12-31 | ₩141.76 Billion ≈ $96.07 Million |
-- |
About Huons Global Co. Ltd
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and inj… Read more